Literature DB >> 32324294

A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets.

Paolo Rebulla1, Frederic Garban2, Pieter F van der Meer3, Nancy M Heddle4, Jeffrey McCullough5.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32324294     DOI： 10.1111/trf.15791

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  4 in total

1.  Improving the safety of platelet transfusions by UV-C: Let's go back to the bench.

Authors:  Daniele Prati
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

2.  Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial.

Authors:  Veronika Brixner; Gesine Bug; Petra Pohler; Doris Krämer; Bernd Metzner; Andreas Voss; Jochen Casper; Ulrich Ritter; Stefan Klein; Nael Alakel; Rudolf Peceny; Hans G Derigs; Frank Stegelmann; Martin Wolf; Hubert Schrezenmeier; Thomas Thiele; Erhard Seifried; Hans-Hermann Kapels; Andrea Döscher; Eduard K Petershofen; Thomas H Müller; Axel Seltsam
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

Review 3.  Pathogen Reduction for Platelets-A Review of Recent Implementation Strategies.

Authors:  Paolo Rebulla; Daniele Prati
Journal:  Pathogens       Date:  2022-01-24

Review 4.  Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic.

Authors:  Gines Escolar; Maribel Diaz-Ricart; Jeffrey McCullough
Journal:  Transfusion       Date:  2021-12-06       Impact factor: 3.337
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.